Vijai Mohan, CEO of STS, on the Impact of COVID-19

Loader Loading...
EAD Logo Taking too long?

Reload Reload document
| Open Open in new tab

[177.86 KB]

Scroll to Top

Federal mandates may constrain platelet availability even more4,9

The safety of platelet transfusions is critical, and recent US Food and Drug Administration (FDA) mandates on bacterial risk mitigation require platelet collections to undergo proactive safety protocols, such as large volume delayed sampling or pathogen reduction. Platelet volume loss due to methods such as these may further erode the platelet supply.4,9